TLI-1186

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTLI-1186
Drug Alias NameTLI-1186
ClassificationSmall molecules
Mechanisms of ActionMu opioid receptor agonistsSerotonin reuptake inhibitorsGlutamate [NMDA] receptor antagonists +[5] 
TargetsVoltage-gated calcium channelGlutamate [NMDA] receptorSerotonin transporter +[5] 
Therapy Area/IndicationsPainDiabetic Neuropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTrinity Laboratories Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTrinity Laboratories Inc
Active IndicationsN/A
Inactive IndicationsPainDiabetic Neuropathies

Other Information

ATC CodeN/A
Related LinksN/A